Evaluation of Dependence and Nicotine Replacement Therapy-Supported Grant uri icon

abstract

  • Electronic cigarette (ECIG) use has increased in recent years, including ECIG use among those who are either never-established cigarette smokers or former smokers who no longer smoke cigarettes. There is a need to better assess ECIG dependence among this population, including whether there are unique indicators of ECIG dependence compared to other tobacco products. Additionally, some ECIG users are interested in cessation, but there are currently no established best-practice methods to support ECIG cessation. The project titled "Evaluation of Dependence and Nicotine Replacement Therapy-Supported Cessation Efforts among Regular Electronic Cigarette Users" aims to examine 1) examine indicators of dependence among current electronic cigarette (ECIG) users who are not current ECIG users, 2) evaluate the effectiveness of nicotine replacement therapy for ECIG use cessation and suppression of withdrawal symptoms, and 3) assess ECIG abstinence using self-report and novel methods. This project is conducted by Dr. Eric Soule (PI) at East Carolina University and Dr. Melissa Blank (PI) at West Virginia University and funded by the National Institutes of Health (R15 funding mechanism).

date/time interval

  • December 2024 - July 2028